EECP (External Counterpulsation Therapy Device)

A non-surgical, non-pharmaceutical treatment device for cardiac and pulmonary rehabilitation. The system is designed for cardiopulmonary rehabilitation, geriatric rehabilitation, chronic disease rehabilitation, and integration of exercise and medicine. The device has received FDA approval in the United States, CE certification in Europe, biocompatibility testing, ISO 13485:2016 quality management system certification, and MDSAP five-country certification.

An integrated external counterpulsation (EECP) device featuring FDA registration and CE certification. The device includes an ergonomically designed treatment bed with adjustable backrest (0-45°), built-in air compressor, and medical touchscreen tablet with 360° planar and 0-90° vertical rotation capabilities for easy observation and operation. The device utilizes advanced digital control circuitry, computer software algorithms, and feedback control technology to ensure precise timing accuracy, safe treatment, and optimal therapeutic efficacy.

Enhanced External Counterpulsation (EECP) is a non-invasive therapeutic device that applies sequential pneumatic pressure to the lower extremities to improve coronary and peripheral circulation. Indicated for cardiovascular rehabilitation, chronic heart disease management, and adjunctive treatment in cardiopulmonary conditions. The system delivers synchronized counterpulsation during diastole to enhance diastolic pressure and improve myocardial perfusion.